-
launched the "Chinese plan" for the treatment of metastatic hormone-sensitive prostate cancer
Time of Update: 2022-09-21
iNatureProstate cancer is a malignant tumor with a very high incidence, ranking second in the world in the incidence of malignant tumors in men, after lung cancer. About 70% of Chinese prostate cancer
-
LANCET Sub-Journal: Abiraterone + Orapali treatment of this prostate cancer can significantly improve PFS
Time of Update: 2022-09-21
(If you need the original text, you can add Xiaobian WeChat yxj_oncology to obtain) 1LANCET Sub-Journal: Abiraterone + Orapali treatment of this prostate cancer can significantly improve PFS▎ Clinical issues: The effect of giving Olapariga abiraterone to metastatic castration-resistant prostate cancer on pain and health-related quality of life (HRQOL) is unclear compared with placebo plus abiraterone therapy.
-
Divine Journal CA Precision Therapy Era: Prostate Cancer Germline Testing Is Indispensable, When Does "Hereditary" Cancer Need Genetic Testing
Time of Update: 2022-05-01
Progression-free survival (PFS) and overall survival (OS) data from multiple precision therapy studies suggest germline and/or somatic mutations in DNA repair genes (eg, BRCA1, BRCA2, ATM, PALB2, FANCA, RAD51D, and CHEK2) Patients with metastatic or advanced prostate cancer are more likely to benefit from PARP inhibitors and platinum-based chemotherapy .
-
BMJ sub-journal: Chinese scholars find that drinking more coffee reduces the risk of prostate cancer in men
Time of Update: 2022-02-24
To investigate the association between coffee intake and prostate cancer risk, the research team searched databases of relevant cohort studies published up to September 2020 .
Overall, this study suggests that increased coffee consumption may be associated with a lower risk of prostate cancer .
-
BMJ Sub-Journal: Chinese scholars found that drinking more coffee reduces the risk of prostate cancer in men
Time of Update: 2022-01-10
To study the association between coffee intake and prostate cancer risk, the research team searched a database of related cohort studies published as of September 2020 .
-
Nature Sub-Journal: The World's Largest Collection of Live Tumors for Patients with Prostate Cancer
Time of Update: 2021-09-03
The PDX collection (patient-derived xenograft) developed by the multidisciplinary consortium led by Professor Gail Risbridger and Associate Professor Renea Taylor of the Monash Biomedical Discovery Institute (BDI) now includes 59 tumors and 30 were collected between 2012 and 2020 It is currently one of the countries with the largest collection of prostate cancer models in the world .
-
Journal of Nuclear Medicine: US single-center study found that black prostate cancer 68Ga-PSMA-11 PET imaging is less likely to be used
Time of Update: 2021-05-20
Among patients undergoing molecular imaging examinations for prostate cancer at a single higher medical center in the United States, through clinical trials, black patients have a significantly limited chance of obtaining 68 Ga-PSMA-11 PET compared with non-Hispanic white patients , nearly four times.
-
BMJ Sub-Journal: Chinese scholars have found that drinking more coffee reduces the risk of prostate
Time of Update: 2021-03-25
To study the association between coffee intake and prostate cancer risk, the research team searched a database of related cohort studies published as of September 2020.
In general, this study shows that increased coffee consumption may be related to lowering the risk of prostate cancer.
-
MiRScientific announces that the validation data for urine-based noninvasive prostate cancer testing are published in the Journal of Urology
Time of Update: 2020-08-12
validation data improves the ability to detect and characterize prostate cancer, sensitivity and specificity exceed 91% SentinelProstateTest ™ data integration to support patient treatment and decision-making Based on published data, the adoption of data shows that can have a very significant impact, significantly improve patient outcomes and reduce unnecessary interventions and waste, miRScientific, LLC announced on August 11th, its urine-based noninvasive cancer detection SentinelTest ™.
-
Science Sub-journal: Revealing the role of androgen receptors in advanced prostate cancer
Time of Update: 2020-06-02
Androgen receptors (ARs) are a driver of cell differentiation and prostate cancer, and are a common therapeutic target for prostate cancer A great deal of research has linked these normal and abnormal